Supercharge Your Innovation With Domain-Expert AI Agents!

Primer composition for detecting SARS-CoV-2 and application thereof

A primer composition, sars-cov-2 technology, applied in the field of genetic engineering, can solve the problems of lack of SARS-CoV-2, insufficient scientific knowledge, accuracy and analysis specificity risks, and achieve rapid detection, good accuracy sexual effect

Active Publication Date: 2021-06-18
GUANGDONG HYBRIBIO BIOTECH CO LTD +3
View PDF5 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] Susceptibility to mutation is an inherent property of most RNA viruses. Reports have revealed the emergence of mutant strains of SARS-CoV-2. SARS-CoV-2 has a proofreading polymerase that can make SARS-CoV -2 has a low probability of base substitution mutations, but SARS-CoV-2 is more prone to deletion mutations, which mostly occur in the recurrent deletion regions (RDRs) of the S protein. As an antibody recognition epitope, deletion mutations of RDRs may lead to changes in the binding specificity of SARS-CoV-2 antibodies, causing antigenic evolution, thereby escaping the neutralizing antibodies induced by pre-mutated SARS-CoV-2
[0006] At present, domestic and foreign detection methods for SARS-CoV-2 mainly focus on two aspects: detection based on PCR amplification of target sequences and sequencing technology (Sanger sequencing, NGS sequencing). The qualitative detection of SARS-CoV-2 nucleic acid is mainly Including reverse transcription + real-time fluorescent quantitative PCR (Real-time PCR), etc., wherein fluorescent PCR technology is simple, fast and sensitive, such as CN111270021A discloses a primer pair, probe, Compositions, kits and applications, the fluorescent RT-RAA primers and fluorescent probes can quickly and qualitatively detect the new coronavirus SARS-CoV-2 in patient samples, but due to the short discovery time of the virus and insufficient scientific knowledge, it is used Gene loci for differential diagnosis have not been validated in large-scale clinical trials, there may be false negatives or false positives, accuracy and analysis-specific risks

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Primer composition for detecting SARS-CoV-2 and application thereof
  • Primer composition for detecting SARS-CoV-2 and application thereof
  • Primer composition for detecting SARS-CoV-2 and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0095] This embodiment provides a SARS-CoV-2 detection kit and its use method, said kit includes the primer composition shown in SEQ ID No.1~12, the sequencing shown in SEQ ID No.7,9,11 Primers, reagents for PCR reaction and Sanger sequencing reagents, among which the reagents for PCR reaction include Baorui Bio’s reverse transcription amplification Mix, Baorui Bio’s mixed enzyme (including hot start Taq enzyme, reverse transcriptase, UNG enzyme), QIAGEN 10×buffer of QIAGEN, 5Q solution of QIAGEN, 25mM Mg of QIAGEN 2+ , 25 mM dNTPs from QIAGEN and H 2 O, the reagent for Sanger sequencing is Thermo Fisher's BigDye Terminatorv3.1 Cycle Sequencing Kit (including: BigDye, 5×seq Buffer).

[0096] The methods of use include:

[0097] (1) Collect nasopharyngeal swab samples;

[0098] (2) Nucleic acid was extracted by magnetic bead method;

[0099] (3) Use the primer combination whose nucleotide sequence is shown in SEQ ID No.1~12 to carry out the amplification reaction,

[0100]...

Embodiment 2

[0123] In this example, the kit and method described in Example 1 are used to detect SARS-CoV-2 (source of the sample: the remaining nucleic acid samples from human specimens detected by Kaipu Medical Laboratory), specifically for SARS-CoV-2 S protein Gene mutations g.21765_21770 del (p.HV 69_70del), g.A22812C (p.K417T), g.G22813C / T (p.K417N), g.G23012A (p.E484K), g.A23063T (p.N501Y) , g.A23403G (p.D614G) and g.C23604A (p.P681H) were detected.

[0124] As shown in Table 5, SEQ ID NO:1,2 and SEQ ID NO:7,8 are respectively the primers of the first round of amplification and the second round of amplification of the g.21765_21770 del (p.HV69_70del) segment, first Carry out the first round of amplification with the primer shown in SEQ ID NO:1,2, and carry out the second round of amplification with the primer shown in SEQ ID NO:7,8, obtain No. 1 amplification product, likewise, with SEQID NO The first round of amplification is carried out with primers shown in 3 and 4, and the seco...

Embodiment 3

[0126] This example uses the kit and method described in Example 1 to detect SARS-CoV-2 (sample source: RNA sample of pseudovirus, pseudovirus purchased from Guangzhou Aiji Biotechnology Co., Ltd.), specifically for SARS-CoV -2 S protein gene mutations g.21765_21770 del (p.HV 69_70del), g.A22812C (p.K417T), g.G22813C / T (p.K417N), g.G23012A (p.E484K), g.A23063T ( p.N501Y), g.A23403G (p.D614G) and g.C23604A (p.P681H) were detected.

[0127] As shown in Table 5, SEQ ID NO:1,2 and SEQ ID NO:7,8 are respectively the primers of the first round of amplification and the second round of amplification of the g.21765_21770 del (p.HV69_70del) segment, first Carry out the first round of amplification with the primer shown in SEQ ID NO:1,2, and carry out the second round of amplification with the primer shown in SEQ ID NO:7,8, obtain No. 1 amplification product, likewise, with SEQID NO The first round of amplification is carried out with primers shown in 3 and 4, and the second round of am...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a primer composition for detecting SARS-CoV-2 and application thereof. The primer composition comprises nucleic acid sequences shown as SEQ ID NO: 1 to SEQ ID NO: 12. The primer composition is used for reverse transcription nested PCR; Sanger sequencing is combined; the SARS-CoV-2 gene information can be fast and accurately obtained, so that the fast detection of SARS-CoV-2 and the judgment of SARS-CoV-2 mutant strains can be realized; and good accuracy, sensitivity, specificity and repeatability are realized.

Description

technical field [0001] The invention belongs to the technical field of genetic engineering, and relates to a primer composition for detecting SARS-CoV-2 and an application thereof. Background technique [0002] Coronaviruses belong to the order Nesting Viridae, the family Coronaviridae, and the genus Coronaviridae. They are a class of RNA viruses with an envelope and a linear single-stranded positive strand genome. They are a class of viruses that exist widely in nature. Certain coronaviruses infect humans and cause disease, such as Middle East Respiratory Syndrome (MERS), Severe Acute Respiratory Syndrome (SARS), and pneumonia caused by SARS-CoV-2, which can range from the common cold to severe lung infections. [0003] Pneumonia caused by SARS-CoV-2 is mainly characterized by fever, fatigue and dry cough. A small number of patients have symptoms such as nasal congestion, runny nose, and diarrhea. Detection of SARS-CoV-2 on suspected cases of pneumonia infected by SARS-Co...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12Q1/70C12Q1/6869C12N15/11C12R1/93
CPCC12Q1/6869C12Q1/701C12Q2600/166C12Q2531/113C12Q2549/119C12Q2545/101C12Q2535/101
Inventor 陈佩璇郑焱丰晓威刘翔黄嫣丽盘璇卢炫廷吴玉莲盘耀亮
Owner GUANGDONG HYBRIBIO BIOTECH CO LTD
Features
  • R&D
  • Intellectual Property
  • Life Sciences
  • Materials
  • Tech Scout
Why Patsnap Eureka
  • Unparalleled Data Quality
  • Higher Quality Content
  • 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More